Printer Friendly

Antidepressant slows patient decline.

The drug Zoloft, commonly used for depression, also improves quality of life and alleviates disruption in daily activities for the one-quarter of Alzheimer's patients who also suffer from major depression, maintain researchers at Johns Hopkins University, Baltimore, Md. However, the drug does not improve patients' cognitive abilities, such as thinking remembering, and learning, which are often impaired in Alzheimer's disease cases.

"Depression in Alzheimer's patients, and even Alzheimer's disease itself, often goes undiagnosed, in part because doctors feel they have little to offer in the form of treatment. This study shows that a simple treatment for depression improves the quality of life and seems to slow the functional decline of Alzheimer's disease," conveys Constantine Lyketsos, professor of psychiatry and behavioral sciences.

Major depression affects 25% of patients with Alzheimer's disease. When combined with the cognitive impairment typical of the debilitating ailment, depression is extremely disabling and can lead to suicide. "This simple and safe treatment for depression has tremendous potential for improving the quality of life for both Alzheimer's patients and their caregivers," indicates Lyketsos.

The results show that 84% of those receiving Zoloft were influenced positively. The researchers found that treating depression was accompanied by lessened behavioral disturbances and improved activities of daily living as well.
COPYRIGHT 2003 Society for the Advancement of Education
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Alzheimer's Disease
Publication:USA Today (Magazine)
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 1, 2003
Words:207
Previous Article:Do energy bars lower insulin levels?
Next Article:Cell death remains key to Alzheimer's.
Topics:


Related Articles
Alzheimer's disease: what we know now.
EUNOE'S COGNISHUNT MAY STABILIZE ALZHEIMER'S PATIENTS.
Making Alzheimer's treatment decisions.
Key clues differentiate Alzheimer's from Lewy body dementia.
Brain imaging shows early Alzheimer-like changes.
Black Alzheimer's caregivers less likely to be depressed.
Neuron savers: gene therapy slows Alzheimer's disease.
Tarenflurbil slows decline in early AD.
Diabetes, high cholesterol linked to faster cognitive decline in Alzheimer's patients.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters